620 related articles for article (PubMed ID: 19628179)
1. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study.
Block PC; Burstein S; Casale PN; Kramer PH; Teirstein P; Williams DO; Reisman M
JACC Cardiovasc Interv; 2009 Jul; 2(7):594-600. PubMed ID: 19628179
[TBL] [Abstract][Full Text] [Related]
2. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study.
Bayard YL; Omran H; Neuzil P; Thuesen L; Pichler M; Rowland E; Ramondo A; Ruzyllo W; Budts W; Montalescot G; Brugada P; Serruys PW; Vahanian A; Piéchaud JF; Bartorelli A; Marco J; Probst P; Kuck KH; Ostermayer SH; Büscheck F; Fischer E; Leetz M; Sievert H
EuroIntervention; 2010 Jun; 6(2):220-6. PubMed ID: 20562072
[TBL] [Abstract][Full Text] [Related]
3. Percutaneous left atrial appendage transcatheter occlusion (PLAATO) for stroke prevention in atrial fibrillation: 2-year outcomes.
Park JW; Leithäuser B; Gerk U; Vrsansky M; Jung F
J Invasive Cardiol; 2009 Sep; 21(9):446-50. PubMed ID: 19726815
[TBL] [Abstract][Full Text] [Related]
4. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy.
Viles-Gonzalez JF; Kar S; Douglas P; Dukkipati S; Feldman T; Horton R; Holmes D; Reddy VY
J Am Coll Cardiol; 2012 Mar; 59(10):923-9. PubMed ID: 22381428
[TBL] [Abstract][Full Text] [Related]
5. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials.
Ostermayer SH; Reisman M; Kramer PH; Matthews RV; Gray WA; Block PC; Omran H; Bartorelli AL; Della Bella P; Di Mario C; Pappone C; Casale PN; Moses JW; Poppas A; Williams DO; Meier B; Skanes A; Teirstein PS; Lesh MD; Nakai T; Bayard Y; Billinger K; Trepels T; Krumsdorf U; Sievert H
J Am Coll Cardiol; 2005 Jul; 46(1):9-14. PubMed ID: 15992628
[TBL] [Abstract][Full Text] [Related]
6. Propensity-Matched Comparison of Oral Anticoagulation Versus Antiplatelet Therapy After Left Atrial Appendage Closure With WATCHMAN.
Søndergaard L; Wong YH; Reddy VY; Boersma LVA; Bergmann MW; Doshi S; Kar S; Sievert H; Wehrenberg S; Stein K; Holmes DR
JACC Cardiovasc Interv; 2019 Jun; 12(11):1055-1063. PubMed ID: 31171282
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of percutaneous left atrial appendage closure to prevent thromboembolic events in atrial fibrillation patients with high stroke and bleeding risk.
Seeger J; Bothner C; Dahme T; Gonska B; Scharnbeck D; Markovic S; Rottbauer W; Wöhrle J
Clin Res Cardiol; 2016 Mar; 105(3):225-9. PubMed ID: 26318322
[TBL] [Abstract][Full Text] [Related]
8. Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke.
Viles-Gonzalez JF; Reddy VY; Petru J; Mraz T; Grossova Z; Kralovec S; Neuzil P
J Interv Card Electrophysiol; 2012 Jan; 33(1):69-75. PubMed ID: 21947786
[TBL] [Abstract][Full Text] [Related]
9. Percutaneous closure of the left atrial appendage: a major step forward.
Sievert H; Bayard YL
JACC Cardiovasc Interv; 2009 Jul; 2(7):601-2. PubMed ID: 19628180
[No Abstract] [Full Text] [Related]
10. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes three years after PLAATO implantation.
El-Chami MF; Grow P; Eilen D; Lerakis S; Block PC
Catheter Cardiovasc Interv; 2007 Apr; 69(5):704-7. PubMed ID: 17351923
[TBL] [Abstract][Full Text] [Related]
12. The Left Atrial Appendage: Target for Stroke Reduction in Atrial Fibrillation.
Ramlawi B; Abu Saleh WK; Edgerton J
Methodist Debakey Cardiovasc J; 2015; 11(2):100-3. PubMed ID: 26306127
[TBL] [Abstract][Full Text] [Related]
13. Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience.
Bai R; Horton RP; DI Biase L; Mohanty P; Pump A; Cardinal D; Scallon C; Mohanty S; Santangeli P; Brantes MC; Sanchez J; Burkhardt JD; Zagrodzky JD; Gallinghouse GJ; Natale A
J Cardiovasc Electrophysiol; 2012 May; 23(5):455-61. PubMed ID: 22082312
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience.
Sievert H; Lesh MD; Trepels T; Omran H; Bartorelli A; Della Bella P; Nakai T; Reisman M; DiMario C; Block P; Kramer P; Fleschenberg D; Krumsdorf U; Scherer D
Circulation; 2002 Apr; 105(16):1887-9. PubMed ID: 11997272
[TBL] [Abstract][Full Text] [Related]
15. Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) Trial.
Reddy VY; Doshi SK; Sievert H; Buchbinder M; Neuzil P; Huber K; Halperin JL; Holmes D;
Circulation; 2013 Feb; 127(6):720-9. PubMed ID: 23325525
[TBL] [Abstract][Full Text] [Related]
16. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry.
Reddy VY; Holmes D; Doshi SK; Neuzil P; Kar S
Circulation; 2011 Feb; 123(4):417-24. PubMed ID: 21242484
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation.
Ussia GP; Mulè M; Cammalleri V; Scarabelli M; Barbanti M; Immè S; Mangiafico S; Marchese A; Galassi AR; Tamburino C
Catheter Cardiovasc Interv; 2009 Aug; 74(2):217-22. PubMed ID: 19472361
[TBL] [Abstract][Full Text] [Related]
18. Quality of life assessment in the randomized PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation.
Alli O; Doshi S; Kar S; Reddy V; Sievert H; Mullin C; Swarup V; Whisenant B; Holmes D
J Am Coll Cardiol; 2013 Apr; 61(17):1790-8. PubMed ID: 23500276
[TBL] [Abstract][Full Text] [Related]
19. An endovascular approach to cardioembolic stroke prevention in atrial fibrillation patients.
Nakai T; Lesh M; Ostermayer S; Billinger K; Sievert H
Pacing Clin Electrophysiol; 2003 Jul; 26(7 Pt 2):1604-6. PubMed ID: 12914609
[TBL] [Abstract][Full Text] [Related]
20. Reduction in risk of stroke and bleeding after left atrial appendage closure with LARIAT device in patients with increased risk of stroke and bleeding: Long term results.
Litwinowicz R; Bartus M; Kapelak B; Suwalski P; Lakkireddy D; Lee RJ; Bartus K
Catheter Cardiovasc Interv; 2019 Nov; 94(6):837-842. PubMed ID: 30884101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
